Conference Coverage

An enlightened approach to weight loss using liraglutide

Publish date: November 3, 2016

 

AT OBESITY WEEK 2016

This analysis and the clinical trials on which it was based were sponsored by Novo Nordisk, which markets liraglutide under the brand names Saxenda and Voctoza. The presenter reported receiving research grants from and serving as a consultant to Novo Nordisk and other pharmaceutical companies.

Pages

Recommended Reading

AHA: Limit children’s added sugar intake to 25 g/day
MDedge Endocrinology
Office-based evidence-informed tools guide obesity and eating disorder counseling
MDedge Endocrinology
Roux-en-Y gastric bypass associated with long-term weight loss
MDedge Endocrinology
Patient-reported outcomes tied to long-term outcomes in bariatric surgery
MDedge Endocrinology
OMA publishes pediatric obesity treatment guide
MDedge Endocrinology
Nonalcoholic fatty liver disease estimated to cost $103 billion annually
MDedge Endocrinology
Many overweight Parkinson’s patients have insulin resistance
MDedge Endocrinology
VIDEO: Pre–gastric bypass antibiotics alter gut microbiome
MDedge Endocrinology
Obesity risk rises when kids aren’t active 1 hour a day
MDedge Endocrinology
Body-size awareness linked with BMI decrease in obese children, teens
MDedge Endocrinology